We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Federal Judge Bars Par From Making Generic Adderall XR Due to Patents
Price:
$40.00
Learn More
Survey: Generics Are Considered Major Threat to Branded Drugmakers
Price:
$40.00
Learn More
Report Finds Recommendation Rates From FDA AdComms Fluctuate Wildly
Price:
$40.00
Learn More
Teva Looking to Divest Products Ahead of Allergan Generics Deal
Price:
$40.00
Learn More
Aid Group Negotiates Royalty-Free License on BMS’ Hepatitis C Drug
Price:
$40.00
Learn More
Amgen Looks to Replicate Humira, Files Biosimilar Application With FDA
Price:
$40.00
Learn More
Analysis Shows FDA Approvals for Generics Rising Year-Over Year
Price:
$40.00
Learn More
Express Scripts Backs Inexpensive Challenger to Turing’s Daraprim
Price:
$40.00
Learn More
FDA Takes First Step Toward Revoking Armepharm’s ANDA
Price:
$40.00
Learn More
Obama Signs New Law Extending Exclusivity Period of Controlled Drugs and Biologics
Price:
$40.00
Learn More
FDA Catches Flak for Pushing Back Final Rule on Generic Drug Labeling Changes Once Again
Price:
$40.00
Learn More
IMS Forecasts a 30 Percent Increase in Drug Spending Fueled by Generics
Price:
$40.00
Learn More
Previous
1
2
3
4
5
6
7
8
9
…
21
22
Next